Clinical Trial Update: Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery [NA]

View source ↗

Summary

Clinical study completed evaluating safety and effectiveness of the RxSight Light Adjustable Lens in patients with prior corneal refractive surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Cataract

Drugs mentioned

• RxSight Light Adjustable Lens

Snippet

Sponsor: RxSight, Inc. | Conditions: Aphakia, Cataract | NA | Status: COMPLETED | Results posted: 2021-11-22